A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection

​ Conditions: Mild Cognitive Impairment (MCI); Alzheimer’s Disease (AD)

Interventions: Drug: [18F]Fluorbetazine injection

Sponsors: HTA Co., Ltd.

Recruiting Conditions: Mild Cognitive Impairment (MCI); Alzheimer’s Disease (AD)
Interventions: Drug: [18F]Fluorbetazine injection
Sponsors: HTA Co., Ltd.
Recruiting